## **Core Concept**
The question tests knowledge of cardiac biomarkers, specifically those elevated in myocardial infarction (MI). Cardiac biomarkers are substances that can be measured in the blood to assess cardiac damage. The most commonly used biomarkers include troponins, creatine kinase (CK), and lactate dehydrogenase (LDH).

## **Why the Correct Answer is Right**
The correct answer, **CK-MB**, is a specific isoform of creatine kinase. While troponins (TnT and TnI) are highly specific for cardiac muscle and are elevated in MI, they are not the first enzymes to rise. CK-MB is more specific to the heart than the total CK and starts to rise within 4-6 hours after the onset of MI, peaking around 12-24 hours. However, among the given options and in clinical context, it's essential to note that troponins are actually the first to rise and are more specific, but if we consider "first enzyme," CK-MB is often discussed in this context historically.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Troponin is actually the most specific marker for myocardial infarction and rises early but is not an "enzyme" in the traditional sense; it's a protein.
- **Option B:** LDH is a marker that rises later in the course of MI, typically peaking around 72 hours, making it less useful for early diagnosis.
- **Option D:** AST (aspartate aminotransferase) can be elevated in MI but is not specific for cardiac damage and can be elevated in various other conditions, making it a less reliable marker.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that troponins (TnI and TnT) are the preferred biomarkers for diagnosing MI due to their high sensitivity and specificity for cardiac muscle damage. They start to rise within 2-3 hours of MI onset. CK-MB, while useful, especially in scenarios where troponins are not available or in certain clinical contexts, follows troponin elevation.

## **Correct Answer:** .